Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
ID: 346137Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/346137

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-099.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity aimed at advancing HIV/AIDS research within its mission areas. This initiative encourages applications that focus on high-priority research related to communication disorders influenced by HIV/AIDS, specifically in areas such as hearing, balance, taste, smell, voice, speech, and language. The program is designed to support hypothesis-driven research, including low-risk clinical trials, with a maximum budget of $499,999 in direct costs per year and a project duration of up to five years. Interested applicants can find more details and submit their proposals by the closing date of January 7, 2026, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-099-Full-Announcement.html
    PAR-23-099.html
    The National Institutes of Health (NIH), specifically the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity to stimulate research on HIV/AIDS within its mission areas. This opportunity encourages applications targeting high-priority research areas related to communication disorders influenced by HIV/AIDS, including hearing, balance, taste, smell, voice, speech, and language. The program supports hypothesis-driven research, with applications for low-risk clinical trials being accepted. Key dates include an open submission date of April 7, 2023, with subsequent deadlines in 2023 and 2024. Applications can be submitted by various organizations, including higher education institutions, government entities, and foreign institutions. The maximum budget allowed is $499,999 in direct costs annually, and the project period can extend up to five years. The announcement emphasizes the significance of addressing communication disorders' impact on the lives of individuals living with HIV, which affects both physical health and broader social aspects. As part of the review process, applications will be evaluated based on scientific merit, investigator qualifications, innovation, approach, and the environment where research will occur. The goal is to foster collaborations across disciplines to advance the understanding and treatment of communication challenges in people living with HIV.
    Similar Opportunities
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to HIV/AIDS within the National Institute on Deafness and Other Communication Disorders (NIDCD). This initiative encourages applications that address high-priority research areas identified by the NIH Office of AIDS Research, particularly focusing on the intersections of HIV/AIDS with hearing, communication, and associated disorders. Grants of up to $499,999 in direct costs are available for projects lasting up to five years, with no cost-sharing or matching requirements. Interested applicants, including educational institutions and community organizations, must adhere to NIH guidelines and submit their proposals through Grants.gov by the closing date of January 7, 2028. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD," aimed at stimulating research related to HIV/AIDS and communication disorders. This initiative encourages applications that address high-priority research areas defined by the NIH Office of AIDS Research, focusing on the impact of HIV on hearing, balance, taste, smell, voice, speech, and language, with a budget limit of $275,000 for a two-year project period. Eligible applicants include a diverse range of institutions and organizations, and only low-risk clinical trials that do not require FDA oversight will be supported. Interested parties can find more information and application details at the NIH grants website, with deadlines for submissions ranging from May 2025 to January 2028.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to communication disorders associated with HIV/AIDS. This initiative encourages innovative, hypothesis-driven research that addresses high-priority areas such as hearing, speech, and language, with a focus on low-risk clinical trials that do not require FDA oversight. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with funding available up to $499,999 per year for projects lasting up to five years. Interested parties should submit their applications by January 7, 2026, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the announcement page at https://grants.nih.gov/grants/guide/pa-files/PAR-23-099.html.
    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity titled "Priority HIV/AIDS Research" under the R01 grant mechanism. This initiative aims to stimulate research that aligns with NIH’s priorities regarding HIV/AIDS, particularly focusing on systemic complications such as metabolic, gastrointestinal, and kidney issues arising from HIV, while encouraging the incorporation of health-impeding social determinants of health into research proposals. The anticipated funding amount is $2 million, with plans to support 3 to 5 awards over five years, and applications are due starting May 7, 2025. Interested applicants can find more information and application guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity for low-risk clinical trials in communication disorders under Funding Opportunity Number PAR-24-051. This initiative aims to support investigator-initiated projects that develop effective interventions in areas such as hearing, speech, and language, specifically targeting low-risk clinical trials that do not require FDA oversight and adhere to budget limits of under $500,000 in direct costs per year. The funding is particularly significant for enhancing research in communication disorders, ultimately improving public health outcomes through scientifically validated interventions. Interested applicants can submit proposals starting January 5, 2024, with the opportunity closing on January 8, 2028; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) for cooperative agreements aimed at supporting clinical trials in communication disorders. Applicants are required to propose a single clinical trial that may necessitate FDA oversight, demonstrate efficacy, or involve higher risks, with an emphasis on substantial interaction with NIDCD staff and comprehensive protections for human subjects. This initiative is crucial for advancing research and establishing effective treatments for conditions related to hearing, balance, taste, smell, voice, speech, and language. Interested applicants can access further details and guidelines through the announcement available at NIH Grants, with a budget that may exceed $700,000 in specific circumstances and a closing date for applications set for October 18, 2027.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Development (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) to support R01 grant applications aimed at promoting workforce development among Early Stage and New Investigators in the field of communication disorders. This initiative encourages applications from individuals from diverse backgrounds, particularly those underrepresented in health-related sciences, and allows for innovative research projects without the necessity of preliminary data, provided they demonstrate feasibility. Applicants can request up to $500,000 in direct costs per year, with a total funding commitment of approximately $2.1 million planned for fiscal years 2026 and 2027 to support around 7-8 meritorious projects. Key application dates begin on January 6, 2025, with a closing date of October 6, 2026; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering research grants aimed at translating basic research findings into clinical practice, specifically for communication disorders. This funding opportunity encourages collaborations between basic scientists and clinicians to develop practical applications that address hearing, balance, smell, taste, voice, and language disorders, with a focus on milestone-driven proposals that demonstrate a clear connection to clinical conditions and impactful outcomes. The grants, limited to a maximum of $500,000 in direct costs annually, are expected to support 2-3 awards in FY25, with applications due by October 12, 2027. Interested applicants can find more information and submit their proposals through Grants.gov, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering a funding opportunity titled "NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)." This initiative aims to support cooperative agreements for clinical trials that require FDA oversight, are intended to establish efficacy, or present higher risks to participants, with a budget exceeding $700,000. The funding is crucial for advancing clinical practices in treating communication disorders, emphasizing the inclusion of diverse populations in recruitment and retention strategies. Interested applicants, including various educational and nonprofit organizations, must submit their applications by January 27, 2024, and can find more information at NIH Grants.
    HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research initiatives focused on HIV-associated non-communicable diseases (NCDs) at low- and middle-income country (LMIC) institutions through the R21 Clinical Trial Optional grant. This program aims to support locally relevant research that explores the relationship between HIV infection and the development of NCDs, enhance research capacity, and foster collaborative networks among researchers in LMICs and the U.S. The grant provides funding up to $275,000 over a two-year period, with a submission deadline of December 8, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.